Physician profile
Antonio Sortino
NPI 1043281181
$6,824.21
in general payments reported to CMS, 2019-2025
27 companies · $284 in 2025
The $284 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,800 · 2020: $507 · 2021: $713 · 2022: $302 · 2023: $524 · 2024: $694 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,501.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,792.72 | 2019-2024 | Impella |
| Abbott Laboratories | $522.20 | 2019-2025 | Cardiomems, Portico |
| Atricure, INC. | $519.48 | 2019-2021 | |
| Haemonetics Corporation | $510.70 | 2019-2024 | Teg6s Hemostasis System |
| Medtronic, INC. | $496.48 | 2022-2025 | Corevalve Evolut R |
| Clearflow INC. | $478.35 | 2019 | |
| Boston Scientific Corporation | $439.66 | 2019-2024 | Watchman Access System |
| Davol INC. | $261.47 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $256.31 | 2019-2020 | |
| Edwards Lifesciences Corporation | $230.36 | 2019-2024 | Sapien 3 Ultra Resilia |
| Ethicon US, LLC | $183.34 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $163.37 | 2019-2020 | |
| Livanova USA, INC. | $152.37 | 2019 | |
| Medtronic Vascular, INC. | $115.75 | 2019 | |
| Zimmer Biomet Holdings, INC. | $114.80 | 2019-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $110.56 | 2019-2020 | |
| Stryker Corporation | $98.69 | 2021 | |
| Novo Nordisk INC | $95.25 | 2024 | Wegovy |
| Lsi Solutions INC | $66.28 | 2019 | |
| Baxter Healthcare | $58.77 | 2019 | |
| Mallinckrodt Enterprises LLC | $39.10 | 2019 | |
| Kls-Martin L.P. | $30.63 | 2019 | |
| Pfizer INC. | $23.69 | 2019 | |
| Genzyme Corporation | $23.55 | 2019 | |
| Csl Behring | $15.41 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.70 | 2023 | Camzyos |
| Chiesi USA, INC. | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Sortino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.